Pacira BioSciences Inc. logo

Pacira BioSciences Inc.

PCRX | NASDAQ
Chart Builder DCF Calculator
$24.84
+$0.73 (+3.03%)
Sep 22, 2026, 2:16 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
7.03M -99.56M 41.96M 15.91M 41.98M 145.52M
Depreciation & Amortization
91.02M 78.79M 75.57M 91.5M 28.55M 19.91M
Stock-Based Compensation
57.5M 51.17M 47.9M 48.09M 42.25M 39.92M
Other Working Capital
5.64M 7.07M -31.24M -23.11M 6.49M -9.21M
Other Non-Cash Items
28.22M 156.89M 19.39M 14.15M 20.75M 22.68M
Deferred Income Tax
6.48M 20.62M 15.62M -7.95M 10.87M -126.61M
Change in Working Capital
-38.27M -18.52M -45.78M -16.43M -18.67M -24.39M
Operating Cash Flow
151.99M 189.39M 154.65M 145.27M 125.72M 77.03M
Capital Expenditures
-15.33M -10.64M -15.16M -30.08M -45.87M -37.8M
Cash Acquisitions
-16.7M n/a n/a n/a -420.04M n/a
Purchase of Investments
-142.29M -252.21M -144.37M -400.69M -628.68M -547.68M
Sales Maturities Of Investments
268.88M 179.57M 237.07M 237.58M 1.08B 307.87M
Other Investing Acitivies
4.93M n/a n/a -32M -4M n/a
Investing Cash Flow
99.48M -83.28M 77.54M -225.19M -20.79M -277.61M
Debt Repayment
-218.99M 76.62M -180.76M -427.69M 363.75M 192.62M
Common Stock Repurchased
-148.33M -25M -106K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-5.62M -34.25M -2.16M -1.18M -9.71M 29.69M
Financial Cash Flow
-369.63M 17.36M -183.03M -401.53M 380.69M 222.3M
Net Cash Flow
-118.23M 123.48M 49.16M -481.44M 485.62M 21.73M
Free Cash Flow
136.66M 178.75M 139.49M 115.2M 79.85M 39.23M
Adj. Free Cash Flow
79.16M 127.58M 91.59M 67.11M 37.61M -689K
Maintenance CapEx
-6.12M -762.38K -11.95M n/a -704.34K -34.58M
Growth CapEx
-9.21M -9.87M -3.22M -30.08M -45.16M -3.22M
Owner Earnings
145.88M 188.63M 142.7M 145.27M 125.01M 42.45M

© 2026 bestshares.com. All rights reserved.